SB140: SB140 Optometrists; doctors of optometry to dispense and sell pharmaceutical agents to patients under certain conditions; provide
Last action May 13, 2025 · Effective Date 2025-05-13
Senate Bill 140 lets Georgia optometrists dispense and sell certain non-controlled eye medications directly to patients in their offices, under new recordkeeping and pharmacy board rules.
In plain language
Under current Georgia law, optometrists have been barred from dispensing or selling pharmaceutical agents to patients, even drugs related to eye care. Senate Bill 140 changes that by amending Georgia's optometry law (O.C.G.A. § 43-30-1) and pharmacy law (O.C.G.A. § 26-4-130). The bill authorizes a doctor of optometry to dispense and sell pharmaceutical agents, other than controlled substances, that treat diseases and conditions of the eye and surrounding tissue, as long as the optometrist is on the premises and actively involved, informs the patient how to use the medication, documents the details in the patient's record, keeps retrievable purchase records, and follows State Board of Pharmacy rules. The bill also adds optometrists to the legal definition of a 'practitioner' who can work with pharmacists under Georgia's pharmacy code. It does not expand optometrists' authority to prescribe or administer drugs beyond what the law already allows, and it takes effect as soon as the Governor signs it or it otherwise becomes law.
What the bill does
- Authorizes doctors of optometry to dispense and sell pharmaceutical agents, other than controlled substances, for treating eye diseases and conditions.
- Requires the optometrist to be physically present and actively involved whenever a pharmaceutical agent is dispensed to a patient.
- Requires the optometrist to document the name, strength, quantity, and appropriate use of each dispensed drug in the patient's record.
- Requires optometrists to keep a retrievable record, manual or electronic, of all pharmaceutical agents purchased for dispensing or sale.
- Adds optometrists to the legal definition of 'practitioner' under Georgia's pharmacy law (O.C.G.A. § 26-4-130), letting them interact with pharmacy rules that apply to other licensed prescribers.
- Clarifies that the change does not expand an optometrist's authority to prescribe or administer drugs beyond current law.
Who it affects
Doctors of optometry and their patients are directly affected, along with the State Board of Pharmacy, which sets the rules optometrists must follow when dispensing drugs. Pharmacists and other licensed practitioners covered by Georgia's pharmacy law are also touched because the definition of 'practitioner' changes.
Why it matters
Patients could get certain eye medications directly from their optometrist's office instead of filling a separate prescription at a pharmacy, potentially speeding up treatment for eye conditions. Optometrists would take on new recordkeeping and compliance duties tied to selling those drugs.
Key provisions
- Section 1 revises O.C.G.A. § 26-4-130 to add optometrists to the definition of 'practitioner of the healing arts' under the pharmacy code.
- Section 2 rewrites O.C.G.A. § 43-30-1(2)(H) so that, instead of barring dispensing, it authorizes optometrists to dispense and sell non-controlled pharmaceutical agents tied to eye treatment.
- Section 2 lists five conditions optometrists must meet: being present and involved, informing the patient, documenting the drug in the record, keeping purchase records, and complying with State Board of Pharmacy rules.
- Section 2 states the change does not expand an optometrist's administrative or prescriptive authority.
- Section 3 revises the construction clause in O.C.G.A. § 43-30-13(a), which addresses how the optometry chapter interacts with other drug and medical practice laws.
- Section 4 sets the effective date as the date the Governor signs the bill or it otherwise becomes law without a signature.
Status timeline
- Effective Date 2025-05-13
- Act 194
- Senate Date Signed by Governor (Senate)
- Senate Sent to Governor (Senate)
- Senate Agreed House Amend or Sub (Senate)
- House Passed/Adopted By Substitute (House)
- House Third Readers (House)
- House Committee Favorably Reported By Substitute (House)
Show full history (20 actions)
- House Withdrawn, Recommitted (House)
- House Committee Favorably Reported (House)
- House Second Readers (House)
- House First Readers (House)
- Senate Passed/Adopted (Senate)
- Senate Third Read (Senate)
- Senate Taken from Table (Senate)
- Senate Tabled (Senate)
- Senate Read Second Time (Senate)
- Senate Committee Favorably Reported (Senate)
- Senate Read and Referred (Senate)
- Senate Hopper (Senate)
Sponsors
- Greg Dolezal (R, SD-027)
- Matt Brass (R, SD-006)
- Ed Harbison (D, SD-015)
- Shawn Still (R, SD-048)
- Billy Hickman (R, SD-004)
- Nan Orrock (D, SD-036)
- Matthew Gambill (R, HD-015)
Votes
- Senate voteMarch 6, 2025
54 yea, 1 nay (1 not voting, 0 absent)
- House voteMarch 31, 2025
166 yea, 0 nay (7 not voting, 7 absent)
- Senate voteMarch 31, 2025
52 yea, 0 nay (1 not voting, 3 absent)
Topics
- optometry
- eye care
- pharmacy regulation
- medical licensing
- prescription drugs